Investor Presentation
Verici Dx plc announced an investor presentation for October 27, 2026, at 16:30 GMT, where CEO Sara Barrington will discuss the company's recent successful fundraising. This funding is anticipated to provide sufficient runway to achieve cash-flow breakeven by the end of 2027. The presentation is open to all shareholders and potential investors, with opportunities to submit questions before and during the event.
Select text to share a quote on X · sign in to keep highlights & notes in your VRCI notes
Verici Dx Plc, (AIM: VRCI), a developer of advanced clinical diagnostics for organ transplant, will provide a live online presentation via Investor Meet Company at 16:30 GMT on Tuesday 27 October 2026. Sara Barrington, Chief Executive Officer, will discuss the Company’s successful recent fundraise, which management anticipates will provide sufficient runway to achieve cash-flow breakeven by the end of 2027.
Investors can sign up to Investor Meet Company for free and add to meet Verici Dx via: https://www.investormeetcompany.com/verici-dx-plc/register-investor
Investors who already follow Verici Dx on the Investor Meet Company platform will automatically be invited.
| Verici Dx plc | www.vericidx.com |
| Sara Barrington, CEO | Via Walbrook PR |
| Julian Baines, Chairman | |
| Singer Capital Markets (Nominated Adviser, Joint Broker & Joint Bookrunner) | Tel: +44 (0)20 7496 3000 |
| Russell Cook / Anastassiya Eley / Harry Littlewood | |
| Oberon Capital (Joint Broker & Joint Bookrunner) | Tel: +44 (0)20 3179 0500 |
| Mike Seabrook / Heena Karani | |
| Walbrook PR (Media & Investor Relations) | Tel: +44 (0)20 7933 8780 or vericidx@walbrookpr.com |
| Alice Woodings / Rachel Broad | Mob: +44 (0)7407 804 654 / +44 (0)7747 515 393 |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.